Ahn, I. E., Tian, X., & Wiestner, A. (2020). Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations. N Engl J Med.
Citação norma ChicagoAhn, Inhye E., Xin Tian, and Adrian Wiestner. "Ibrutinib for Chronic Lymphocytic Leukemia With TP53 Alterations." N Engl J Med 2020.
ציטוט MLAAhn, Inhye E., Xin Tian, and Adrian Wiestner. "Ibrutinib for Chronic Lymphocytic Leukemia With TP53 Alterations." N Engl J Med 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.